Dashboard
Manage Tickers

DRRX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Bausch Health To Acquire DURECT For $63M, ...
08/12/2025 20:51:09

Recent business highlights and updates:In July 2025, DURECT announced that it entered into an Agreement and Plan of Merger with...

durect-q2-eps-007-beats-011-estimate-sales-447000k-beat-310000k-estimate
Durect Q2 EPS $(0.07) Beats $(0.11) Estima...
08/12/2025 20:36:48

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 36....

bausch-health-adds-late-stage-ready-alcohol-liver-disease-drug-candidate-in-63-million-durect-buyout
Bausch Health Adds Late-Stage Ready Alcoho...
07/29/2025 18:21:25

Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via P...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 17:06:19

crude-oil-gains-over-1-unitedhealth-earnings-miss-views
Crude Oil Gains Over 1%; UnitedHealth Earn...
07/29/2025 16:53:28

us-stocks-mixed-procter--gamble-posts-upbeat-earnings
US Stocks Mixed; Procter & Gamble Posts Up...
07/29/2025 14:13:18

durect-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-3288
DURECT Shares Halted On Circuit Breaker To...
07/29/2025 14:03:30

durect-shares-resume-trade-following-circuit-breaker-halt
DURECT Shares Resume Trade Following Circu...
07/29/2025 13:58:39

Core News & Articles
Reported Earlier: Bausch Health To Acquire...
07/29/2025 13:56:06

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 12:07:53

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
07/29/2025 11:25:06

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
07/29/2025 10:55:04

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/06/2025 12:07:07

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
05/16/2025 21:05:51

durect-q1-eps-013-misses-012-estimate-sales-32100k-beat-29167k-estimate
Durect Q1 EPS $(0.13) Misses $(0.12) Estim...
05/13/2025 20:23:53

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 8...

hc-wainwright--co-reiterates-neutral-on-durectto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/27/2025 17:26:50

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) from Neutral to Neutral.

durect-q4-2024-gaap-eps-024-beats-002-estimate-sales-500000k-miss-6907m-estimate
Durect Q4 2024 GAAP EPS $0.24 Beats $(0.02...
03/26/2025 20:11:39

Durect (NASDAQ:DRRX) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.02) by 130...

earnings-scheduled-for-march-26-2025
Earnings Scheduled For March 26, 2025
03/26/2025 08:32:12

durect-sells-alzet-osmotic-pumps-for-175m-pays-off-loan-obligations
DURECT Sells ALZET Osmotic Pumps for $17.5...
11/25/2024 11:05:17

DURECT Corporation (NASDAQ:DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to ...

hc-wainwright--co-reiterates-neutral-on-durect
HC Wainwright & Co. Reiterates Neutral on ...
11/14/2024 11:20:39

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION